Article Text
Statistics from Altmetric.com
QUESTION: In women with pre-eclampsia, does magnesium sulphate reduce the risk of eclampsia and improve pregnancy outcome?
Design
Randomised (allocation concealed*), blinded (clinicians, patients, data collectors, and data analysts),* placebo controlled trial with follow up to discharge from hospital after delivery (MAGnesium sulphate for Prevention of Eclampsia [MAGPIE] Trial).
Setting
175 hospitals in 33 countries.
Patients
10 141 women who had not yet given birth or had delivered within <24 hours, had pre-eclampsia (diastolic blood pressure [BP] ≥90 mm Hg, systolic BP ≥140 mm Hg on ≥2 occasions, and proteinuria ≥1+), and clinical uncertainty existed about the use of magnesium sulphate. Exclusion criteria were hypersensitivity to magnesium, hepatic coma with risk of renal failure, or myasthenia gravis. 99.7% of women were included in the analysis.
Intervention
Women were allocated to …
Footnotes
-
Sources of funding: UK Medical Research Council; UK Department for International Development; UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction.
-
For correspondence: Dr L Duley, Resource Centre for Randomised Trials, Oxford, UK. lelia.duley{at}ndm.ox.ac.uk